Practice Point CME

Your Sorted CME/CE Activities

Number of search result: 265

Advanced Case-Based Strategies to Integrate Recent Progress in the Management of PsA

Activity Details

Advanced Case-Based Strategies to Integrate Recent Progress in the Management of PsA

Activity Summary:
The management of Psoriatic Arthritis (PsA) remains challenging, owing to variable clinical presentations and ever-changing therapeutic options. Optimizing outcomes for PsA is dependent upon the early identifying patients, developing a personalized treatment strategy, and cohesively collaborating with a multidisciplinary team to address issues related to the challenges of diagnosis and access to appropriate therapy. Furthermore, research in PsA has evolved in recent years to reflect changes in the current disease landscape, study population, new management strategies, advanced recommendations on assessing patients’ overall disease activity and responses to treatment, healthcare providers’ and patients’ treatment expectations, and regulatory requirements. Understanding these can help guide clinical decision-making and improve outcomes for patients with PsA.

Talking PsA is an accredited AMA/ANCC/ACPE activity that highlights the very latest clinical data and is designed to optimize treatment strategies in PsA through a series of four patient case studies. The content and clinical cases were developed and presented by leading Rheumatology and Dermatology experts in PsA.

Faculty:Philip Mease, MD, MACR and Joseph Merola, MD, MMSc

Accreditation Type:AMA, ANCC and ACPE

Launch Date:October 6, 2022

Release Date:September 27, 2022

Expiration Date: August 31, 2023

Estimated Time to Complete Activity:1 hour

ACCESS THIS ACTIVITY

Novel Therapeutic Approaches to Improve Outcomes for Patients with PAH

Activity Details

Novel Therapeutic Approaches to Improve Outcomes for Patients with PAH

Activity Summary:
Talking PAH is a webcast series that highlights the very latest clinical data in pulmonary arterial hypertension. Slides are developed and presented by leading PAH expert physicians and further reviewed and approved by the planning committee.

Pulmonary arterial hypertension (PAH) is a progressive and fatal lung disease of multifactorial etiology. Currently, therapies for treating pulmonary hypertension have been used alone and in combination to demonstrate improvements in quality of life and hemodynamic parameters as well as in slowing disease progression; however, beneficial effects on survival are limited. None offer a cure against PAH nor directly address the underlying cellular proliferation that leads to increased pulmonary arterial pressure, and the median survival rate remains at 61% at five years after diagnosis. Extensive research efforts have led to the emergence of innovative therapeutic approaches in PAH. This on-demand webcast focuses on several important aspects of PAH management, including a discussion of the challenges diagnosing and treating patients, clinical trial data on emerging therapeutics for the management of PAH, and a review of strategies to optimize outcomes for patients with PAH.

Faculty:Aaron Waxman, MD, PhD, FACP, FCCP and Mardi Gomberg-Maitland, MD, MSc

Accreditation Type:AMA, ANCC and ACPE

Launch Date:September 30, 2022

Release Date:September 15, 2022

Expiration Date: August 31, 2023

Estimated Time to Complete Activity:1 hour

ACCESS THIS ACTIVITY

Conversations in HIV Prevention: Successful Strategies to Implement PrEP and Maintain Patient Engagement

Activity Details

Conversations in HIV Prevention: Successful Strategies to Implement PrEP and Maintain Patient Engagement

Activity Summary:
The expansion of PrEP provision could help to stem the number of new HIV infections globally. Studies are underway to optimize their tolerability with novel regimens and methods of delivery in the hope that persons with diverse patterns of sexual risk and personal preferences will find chemoprophylaxis to be acceptable and beneficial. However, in addition to antiretroviral regimen tolerability and efficacy, there are clearly social and behavioral factors that impact adherence to medications and associated clinical monitoring, which remain suboptimal in some populations; developing interventions to support adherence to chemoprophylaxis will be essential.

In this episode of Conversations in HIV, the faculty engages in a thought-provoking discussion identifying strategies to facilitate successful and sustainable implementation of PrEP for specific patients to include a MSM and IDU at Risk for HIV, Cisgender Woman Without HIV and MSM with Multiple Comorbidities.

Faculty:Meredith Clement, MD, Raphael J Landovitz, MD, MSc and Hyman Scott, MD, MPH

Accreditation Type:AMA, ANCC and ACPE

Launch Date:September 26, 2022

Release Date:September 26, 2022

Expiration Date: August 31, 2023

Estimated Time to Complete Activity:1 Hour

ACCESS THIS ACTIVITY

Moving Towards Ending the HIV Epidemic: Strengthening HIV Prevention and Care in the South - Cisgender Women Population

Activity Details

Moving Towards Ending the HIV Epidemic: Strengthening HIV Prevention and Care in the South - Cisgender Women Population

Activity Summary:
This accredited continuing education webcast archive was presented by HIV specialists who practice in the southern United States. Geographically appropriate topics and practical strategies for cisgender women such as ending the HIV epidemic, HIV/STI screening, and HIV prevention/treatment considerations are discussed.

Faculty:Ronnie Gravett, MD, DTM&H and Caitlin Moran, MD, MSc

Accreditation Type:AMA, ANCC and ACPE

Launch Date:September 26, 2022

Release Date:September 20, 2022

Expiration Date: August 31, 2023

Estimated Time to Complete Activity:1 hour

ACCESS THIS ACTIVITY

Case-Based Strategies to Integrate Recent Progress in Pulmonary Hypertension Due to Interstitial Lung Disease

Activity Details

Case-Based Strategies to Integrate Recent Progress in Pulmonary Hypertension Due to Interstitial Lung Disease

Activity Summary:
Clinical Viewpoints PH-ILD includes a curriculum that highlights the very latest clinical data in pulmonary hypertension due to interstitial lung disease (PH-ILD). Slides are developed and updated throughout the year by leading pulmonology expert physicians. All content is reviewed and approved by the Clinical Viewpoints PH-ILD Planning Committee.

Patients with PH-ILD face a dismal prognosis and are associated with reduced exercise capacity, greater need for supplemental oxygen, and a decreased quality of life. In recent years, there have been several advances in the treatment and management of PH-ILD. This slide kit will use three case scenarios to illustrate best-practice approaches to accurately diagnose PH-ILD and differentiate it from group 1 pulmonary arterial hypertension (PAH). It will also provide guidance on integrating recent progress in the treatment of PH-ILD and on the safe and effective use of approved and emerging therapy.

Faculty:Steven Nathan, MD

Accreditation Type:AMA, ANCC and ACPE

Launch Date:September 22, 2022

Release Date:September 22, 2022

Expiration Date: August 31, 2023

Estimated Time to Complete Activity:.5 hours

ACCESS THIS ACTIVITY

Talking Post-Transplant Acute Myeloid Leukemia - Improving Outcomes after Relapse: A CME Webcast Series

Activity Details

Talking Post-Transplant Acute Myeloid Leukemia - Improving Outcomes after Relapse: A CME Webcast Series

Activity Summary:
The Talking Post-Transplant Acute Myeloid Leukemia (AML) webcast series will provide recent updates to improve outcomes in post-transplantation relapse in AML.

This webcast series, led by expert faculty, will provide guidance and practical strategies to safely implement recent progress in addressing post-transplantation relapse in AML. Through patient cases and scenarios, faculty presenters will guide the integration of new evidence into clinical treatment paradigms of AML in the post-transplantation setting. The activity will be supported by downloadable slides that have the key discussion/teaching points.

To register, please click your preferred date/time from the webcasts provided.

Faculty:Daniel Pollyea, MD, Keith Pratz, MD, Gail Roboz, MD and Robert Soiffer, MD

Accreditation Type:AMA

Launch Date:

Release Date:

Expiration Date:

Estimated Time to Complete Activity:

ACCESS THIS ACTIVITY

Talking Multiple Myeloma: Strategies to Treat and Manage Patients in the Frontline and Beyond

Activity Details

Talking Multiple Myeloma: Strategies to Treat and Manage Patients in the Frontline and Beyond

Activity Summary:
The Talking Multiple Myeloma webcast archive will highlight recent advances in the initial management of multiple myeloma (MM).

Through patient cases and scenarios, the expert faculty presenters will discuss practice-changing updates in the initial management of MM, strategies to improve patient outcomes and prevent/manage adverse events as well as guide the integration of new evidence into clinical treatment paradigms.

Faculty:Andew Cowan, MD and Nina Shah, MD

Accreditation Type:AMA

Launch Date:September 16, 2022

Release Date:September 16, 2022

Expiration Date: August 31, 2023

Estimated Time to Complete Activity:1 Hour

ACCESS THIS ACTIVITY

Talking COPD: A Live Webcast Series

Activity Details

Talking COPD: A Live Webcast Series

Activity Summary:
Talking COPD is a webcast series that highlights the very latest clinical data in chronic obstructive pulmonary disease. Slides are developed and presented by leading COPD expert physicians and further reviewed and approved by the planning committee. Talking COPD offers various topics that can be accessed for AMA, ANCC or ACPE credit.

Continue to visit this page throughout 2022 to register for the interactive opportunity with a COPD expert through our live webcast. If you are unable to make the live webcast, you will be able to access the archived video here for credit.

Faculty:Nicholas Hill, MD and Robert Schilz, DO, PhD

Accreditation Type:AMA, ANCC and ACPE

Launch Date:

Release Date:

Expiration Date:

Estimated Time to Complete Activity:

ACCESS THIS ACTIVITY

Conversations in Oncology: Updates in the Treatment of Early Non-Small Cell Lung Cancer

Activity Details

Conversations in Oncology: Updates in the Treatment of Early Non-Small Cell Lung Cancer

Activity Summary:
With the recent approval of atezolizumab and osimertinib, and several ongoing trials, it has become clear that immunotherapy and targeted approaches are gaining ground in the adjuvant and neoadjuvant setting of early-stage non-small cell lung cancer (NSCLC). Considering the continual updates from clinical trials in this space, it is pivotal that healthcare professionals are familiar with the practical considerations to safely integrate this recent progress.

This activity will highlight the practice-changing updates in adjuvant and neoadjuvant approaches in early-stage NSCLC, to enable safe and effective implementation into clinical practice through expert-guided discussions with Drs. Julie Brahmer, Jamie Chaft and Stephen Liu.

Faculty:Julie R. Brahmer, MD, MSc, Jamie Chaft, MD and Stephen Liu, MD

Accreditation Type:AMA and ANCC

Launch Date:September 12, 2022

Release Date:September 12, 2022

Expiration Date: August 31, 2023

Estimated Time to Complete Activity:1 hour

ACCESS THIS ACTIVITY

Patient Perspectives in HIV: A CE Podcast Series

Activity Details

Patient Perspectives in HIV: A CE Podcast Series

Activity Summary:
Patient Perspectives in HIV: A CE Podcast Series is an accredited continuing education series of podcasts as downloadable audio files (MP3). These podcasts will be recorded and made available throughout the year.

In this series of podcasts, the content faculty and one of their patients will discuss considerations and challenges in the prevention and treatment of HIV. Topics covered will include patient concerns, benefits and risks of antiretroviral therapy, and how patients have handled challenges in their HIV management.

Faculty:Darcy Wooten, MD

Accreditation Type:AMA, ANCC and ACPE

Launch Date:July 14, 2022

Release Date:June 30, 2022

Expiration Date: August 31, 2023

Estimated Time to Complete Activity:AMA, ANCC and ACPE

ACCESS THIS ACTIVITY

Advanced Treatments in PAH: A Case-Based Approach

Activity Details

Advanced Treatments in PAH: A Case-Based Approach

Faculty:Ronald Oudiz, MD, FACP, FACC, FCCP and Vijay Balasubramanian MD, MRCP (UK)

Accreditation Type:AMA, ANCC and ACPE

Launch Date:August 25, 2022

Release Date:August 10, 2022

Expiration Date: July 31, 2023

Estimated Time to Complete Activity:1 hour

ACCESS THIS ACTIVITY

Talking Philadelphia Positive Acute Lymphoblastic Leukemia (Ph+ ALL): Improving Outcomes of Frontline Treatment and Mitigating Relapse

Activity Details

Talking Philadelphia Positive Acute Lymphoblastic Leukemia (Ph+ ALL): Improving Outcomes of Frontline Treatment and Mitigating Relapse

Activity Summary:
Combining tyrosine kinase inhibitor and immunotherapy agents has shown considerable promise in Philadelphia positive acute lymphoblastic leukemia (Ph+ ALL). Although this approach can provide a chemotherapy-free and transplantation-sparing alternative, it is imperative that healthcare professionals are familiar with the practical considerations to safely integrate this recent progress.

This certified AMA activity will highlight the practice-changing updates in the frontline treatment of Ph+ ALL and provide guidance on effective implementation of new evidence through expert-guided discussions and interactive case scenarios.

Faculty:Katarzyna Jamieson, MD, Farhad Ravandi, MD and Richard Stone, MD

Accreditation Type:AMA

Launch Date:August 23, 2022

Release Date:August 23, 2022

Expiration Date: July 31, 2023

Estimated Time to Complete Activity:1 hour

ACCESS THIS ACTIVITY

Current and Emerging Perspectives in Chronic Immune Thrombocytopenia - Updated 8/18/2022

Activity Details

Current and Emerging Perspectives in Chronic Immune Thrombocytopenia - Updated 8/18/2022

Activity Summary:
Immune thrombocytopenic purpura (ITP) is a hematological autoimmune disorder characterized by low platelet count in the blood, which may lead to bruising and bleeding. For many years, immune-modulating therapies, such as corticosteroids, immunoglobulins (IVIG and anti-RhD), and rituximab, were the mainstays of treatment in ITP. Since 2008, the approval of thrombopoietin-receptor agonists (TPO-RAs) including a second-generation oral TPO-RA and a spleen tyrosine kinase (Syk) inhibitor, revolutionized the treatment landscape of ITP by opening new and highly effective avenues of treatment. This landscape will be further transformed with a sizable clinical pipeline including inhibitors of CD20, CD40, neonatal Fc receptor (FcRn), bruton’s tyrosine kinase (BTK), and Syk signaling.

This slide kit is designed to keep busy clinicians abreast of the emerging evidence for available treatments and the novel therapy pipeline, to optimize the treatment and care for patients with ITP.

Updated information is noted on the slide in the upper right hand corner. Please note that participants who have previously claimed credit for this activity should not claim duplicate credit based on the updates.

Faculty:Hanny Al-Samkari, MD

Accreditation Type:AMA and ANCC

Launch Date:August 30, 2021

Release Date:August 30, 2021

Expiration Date: December 31, 2022

Estimated Time to Complete Activity:1 hour

ACCESS THIS ACTIVITY

Moving Towards Ending the HIV Epidemic: Strengthening HIV Prevention and Care in the South

Activity Details

Moving Towards Ending the HIV Epidemic: Strengthening HIV Prevention and Care in the South

Activity Summary:
Currently the South is the epicenter of the HIV epidemic in the United States. It experiences the greatest burden of HIV and deaths, and improvement is needed in providing HIV prevention services and care. Closing these gaps is essential to the health of people in the region and meeting the national goal of ending the HIV epidemic.

These accredited continuing education webcasts will be presented by HIV specialists who practice in the Southern United States. Geographically appropriate topics and practical strategies such as Adolescence, Sexual and Gender Minorities and Cisgender Women populations will be discussed.

Faculty:Physicians from the southern region of the United States

Accreditation Type:AMA, ANCC and ACPE

Launch Date:

Release Date:

Expiration Date:

Estimated Time to Complete Activity:

ACCESS THIS ACTIVITY

Moving Towards Ending the HIV Epidemic: Strengthening HIV Prevention and Care in the South - Sexual and Gender Minorities

Activity Details

Moving Towards Ending the HIV Epidemic: Strengthening HIV Prevention and Care in the South - Sexual and Gender Minorities

Activity Summary:

This accredited continuing education webcast archive was presented by HIV specialists who practice in the southern United States. Geographically appropriate topics and practical strategies within sexual and gender minorities such as ending the HIV epidemic, HIV/STI screening, and HIV prevention/treatment considerations are discussed.

Faculty:Ronnie Gravett, MD, DTM&H and Meredith Clement, MD

Accreditation Type:AMA, ANCC and ACPE

Launch Date:August 9, 2022

Release Date:August 9, 2022

Expiration Date: July 31, 2023

Estimated Time to Complete Activity:1 hour

ACCESS THIS ACTIVITY

Conversations in PAH: Global Trends in PH Clinical Trials and Risk Assessment

Activity Details

Conversations in PAH: Global Trends in PH Clinical Trials and Risk Assessment

Activity Summary:
This AMA/ANCC/ACPE activity features a recorded discussion among three leading pulmonary hypertension (PH) experts and is designed to keep healthcare professionals on top of the most recent clinical findings.

New information is constantly being learned about the management of patients with PH. Pulmonary Hypertension Due to Interstitial Lung Disease (PH-ILD) represents a complex condition which now has a recently approved inhaled therapy to improve exercise ability. Chronic thromboembolic pulmonary hypertension (CTEPH) is a rare but treatable complication of PE, which is often indistinguishable from pulmonary arterial hypertension (PAH). All patients with PH benefit from intensive, continuous clinical monitoring either in person or remotely to guide escalation of treatments. PH remains a disease with poor outcomes, necessitating early diagnosis and appropriate intervention. Improvements in survival and care depends on improving clinician awareness of the latest research and perspectives. This activity brings cutting-edge research to busy clinicians enabling them to readily keep abreast of emerging published research as it relates to the management of PH.

Faculty:Ronald Oudiz, MD, FACP, FACC, FCCP, Steven Nathan, MD and Nick Kim, MD

Accreditation Type:AMA, ANCC and ACPE

Launch Date:August 4, 2022

Release Date:July 18, 2022

Expiration Date: June 30, 2023

Estimated Time to Complete Activity:1 hour

ACCESS THIS ACTIVITY

Conversations in PAH: An Expert Discussion on Clinical Updates and Treatment Options in PAH

Activity Details

Conversations in PAH: An Expert Discussion on Clinical Updates and Treatment Options in PAH

Activity Summary:
Conversations in PAH are accredited, on-demand video presentations that feature leading experts discussing hot topics, recent clinical updates, conference updates and treatment options for managing patients with PH. This activity is designed to keep healthcare professionals on top of the most recent clinical findings. Two video series will be launched in 2022.

Faculty:Faculty varies by activity

Accreditation Type:AMA, ANCC and ACPE

Launch Date:

Release Date:

Expiration Date:

Estimated Time to Complete Activity:1 Hour per Module

ACCESS THIS ACTIVITY

Independent Coverage from the 24th International AIDS Conference (AIDS 2022)*

Activity Details

Independent Coverage from the 24th International AIDS Conference (AIDS 2022)*

Activity Summary:
Advances in HIV research often unfold rapidly. In order to deliver state-of-the-art care, healthcare providers who manage this patient population must stay abreast of data emerging from the major conferences.

These educational Clinical Clips will spotlight the latest advances in the treatment and prevention of HIV and related comorbidities with a series of ‘what you need to know’ videos from data presented during from the 24th International AIDS Conference.

Faculty:Daniel Kuritzkes, MD

Accreditation Type:AMA, ANCC and ACPE

Launch Date:July 30, 2022

Release Date:July 30, 2022

Expiration Date: June 30, 2023

Estimated Time to Complete Activity:1 hour

ACCESS THIS ACTIVITY

Quarterly Brief (April-June, 2022): A Current Expert Analysis on Important HIV Clinical Decisions

Activity Details

Quarterly Brief (April-June, 2022): A Current Expert Analysis on Important HIV Clinical Decisions

Activity Summary:
New frontiers for HIV therapy continue to be explored, as underscored by the clinical development and use of new agents, changing regimen strategies and development of long-acting novel agents. This expanding era of simplified and effective HIV therapy presents physicians with many new opportunities and challenges for providing care. To deliver state-of-the-art HIV prevention and care, healthcare providers must stay informed regularly of new clinical data and treatment recommendations in HIV.

This educational Quarterly Brief, covering HIV data from April through June of 2022 will discuss the most clinically relevant information regarding HIV Epidemiology and Prevention, Treatment-Experienced Patients and Pregnancy and Non-ART.

Faculty:Paul Sax, MD and Aadia Rana, MD

Accreditation Type:AMA, ANCC and ACPE

Launch Date:July 28, 2022

Release Date:July 28, 2022

Expiration Date: June 30, 2023

Estimated Time to Complete Activity:0.5 Hours

ACCESS THIS ACTIVITY

Learning from Success: Improving Outcomes with New HIV ART Options (Series 1 of 2)

Activity Details

Learning from Success: Improving Outcomes with New HIV ART Options (Series 1 of 2)

Activity Summary:

Recognizing and discussing significant developments and strategies in ART places healthcare professionals at the forefront of HIV care. In addition, new frontiers for HIV therapy continue to be explored, as underscored by the clinical development of long-acting regimens and first-in-class antiretroviral agents.

This activity will provide a discussion-based format, from an innovative HIV clinic, to discuss the advantages and limitations of current ART, the implementation of new ART classes/formulations, and the impact new drugs/formulations have on ART management.

Faculty:Anthony Mills, MD

Accreditation Type:AMA, ANCC and ACPE

Launch Date:July 25, 2022

Release Date:July 25, 2022

Expiration Date: June 30, 2023

Estimated Time to Complete Activity:1 Hour

ACCESS THIS ACTIVITY

CME/CE Activity Sorter
(Select therapeutic category and activity type of interest and view your sorted activities below)

Your Sorted CME/CE Activities

Advanced Case-Based Strategies to Integrate Recent Progress in the Management of PsA

Novel Therapeutic Approaches to Improve Outcomes for Patients with PAH

Conversations in HIV Prevention: Successful Strategies to Implement PrEP and Maintain Patient Engagement

Moving Towards Ending the HIV Epidemic: Strengthening HIV Prevention and Care in the South - Cisgender Women Population

Case-Based Strategies to Integrate Recent Progress in Pulmonary Hypertension Due to Interstitial Lung Disease

Talking Post-Transplant Acute Myeloid Leukemia - Improving Outcomes after Relapse: A CME Webcast Series

Talking Multiple Myeloma: Strategies to Treat and Manage Patients in the Frontline and Beyond

Talking COPD: A Live Webcast Series

Conversations in Oncology: Updates in the Treatment of Early Non-Small Cell Lung Cancer

Patient Perspectives in HIV: A CE Podcast Series

Advanced Treatments in PAH: A Case-Based Approach

Talking Philadelphia Positive Acute Lymphoblastic Leukemia (Ph+ ALL): Improving Outcomes of Frontline Treatment and Mitigating Relapse

Current and Emerging Perspectives in Chronic Immune Thrombocytopenia - Updated 8/18/2022

Moving Towards Ending the HIV Epidemic: Strengthening HIV Prevention and Care in the South

Moving Towards Ending the HIV Epidemic: Strengthening HIV Prevention and Care in the South - Sexual and Gender Minorities

Conversations in PAH: Global Trends in PH Clinical Trials and Risk Assessment

Conversations in PAH: An Expert Discussion on Clinical Updates and Treatment Options in PAH

Independent Coverage from the 24th International AIDS Conference (AIDS 2022)*

Quarterly Brief (April-June, 2022): A Current Expert Analysis on Important HIV Clinical Decisions

Learning from Success: Improving Outcomes with New HIV ART Options (Series 1 of 2)